Community Hospital of Monterey Peninsula — Monterey, California

Community Hospital of Monterey Peninsula is a clinical research site located in Monterey, California, United States 93940.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Community Hospital of Monterey Peninsula has participated in 24 clinical trials with 10 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network, NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Monterey

Browse all research sites in California · View every site in Monterey

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Community Hospital of Monterey Peninsula?

Community Hospital of Monterey Peninsula has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Community Hospital of Monterey Peninsula conducted?

Community Hospital of Monterey Peninsula has 24 clinical trials on record, with 10 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Community Hospital of Monterey Peninsula accredited by Crixeo Clinical Trials?

Community Hospital of Monterey Peninsula has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Community Hospital of Monterey Peninsula?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.